Cargando…
Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides
There is a crucial need to identify new biomarkers associated with aggressive prostate cancer (PCa) including those associated with cancer stem cells (CSCs). CD44v6, generated by alternative splicing of CD44, has been proposed as a CSC biomarker due to its correlation with aggressive PCa disease. We...
Autores principales: | Peng, Ying, Prater, Austin R., Deutscher, Susan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689723/ https://www.ncbi.nlm.nih.gov/pubmed/29156833 http://dx.doi.org/10.18632/oncotarget.21421 |
Ejemplares similares
-
Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting
por: Zhang, Dan, et al.
Publicado: (2020) -
Selection of silk-binding peptides by phage display
por: Nomura, Yoko, et al.
Publicado: (2011) -
Selective inhibition of miR-21 by phage display screened peptide
por: Bose, Debojit, et al.
Publicado: (2015) -
Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library
por: Demartis, Anna, et al.
Publicado: (2018) -
CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells
por: Li, Linxian, et al.
Publicado: (2016)